Seeking Alpha

ViroPharma Inc. (VPHM)

()

News & PR
Market Currents

Buzz
Twitter: VPHM

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Dyax: FDA Approval Boosts Prospects

Dec 3 • EP Vantage • Comment!
Biotech Stocks for a Possible Year-End Rally

Nov 18 • R. Scott Raynovich • 2 Comments
Biotech: Q3 Market Update

Oct 16 • R. Scott Raynovich • Comment!
Clolar Decision Aside, Genzyme's Still a Near-Term Sell

Sep 2 • Mark Mitchell • Comment!
ViroPharma Finally Able to Look Forward

Aug 6 • EP Vantage • Comment!
FDA Calendar Updates: ViroPharma, Electro-Optical Sciences, Wyeth, Progenics

Aug 5 • Mike Havrilla • Comment!
Research Metrics for 30 Dividend Stocks

Jul 22 • MagicDiligence • Comment!
Contrarian Stock Screen: Biggest Losers in 2009

Jul 12 • The Manual of Ideas • 3 Comments
Smaller Pharma Wins the 'Most Valuable' Race

Jul 1 • EP Vantage • 1 Comment
FDA Calendar Updates: ABT, AFFY, AZN, LLY, MELA, PFE, SOMX, VPHM

Jun 5 • Mike Havrilla • Comment!
ViroPharma: FDA Issues Complete Response Letter for Cinryze

Jun 4 • Zacks.com • 1 Comment
Friday Options Recap

May 29 • Frederic Ruffy • 2 Comments
Buying ViroPharma Ahead of June 3rd FDA Decision

May 28 • Mark Cifra • 12 Comments
Wall Street Breakfast: Must-Know News

Apr 29 • SA Editor Rachael Granby • 30 Comments
Top 10 Dividend, P/S and P/B Ratio Stocks

Apr 28 • MagicDiligence • 5 Comments
Does More Cash and Less Debt Equal Stock Market Gains?

Apr 23 • Trade Radar Operator • 1 Comment
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly

Apr 2 • Mark Cifra • 5 Comments
Monday's Options Recap

Mar 23 • Frederic Ruffy • 2 Comments
Wall Street Breakfast: Must-Know News

Feb 24 • SA Editor Rachael Granby • 13 Comments
Viropharma: Failed Bet on Orphan Drug

Feb 10 • Donald Johnson • 1 Comment
Viropharma's Antiviral Bombs: Here We Go Again

Feb 10 • Derek Lowe • Comment!
9 Possible Pharma Deals for 2009

Jan 8 • Zacks.com • 7 Comments
2009: Positive Outlook for Biotech

Jan 8 • Michael Becker • 1 Comment
2008 Stock Market: 51 Rays of Light

Jan 7 • Market Folly • 1 Comment
New Index of Health Product Innovators

Jan 5 • Mike Havrilla • Comment!
Weekly FDA Calendar Update

Dec 7, 2008 • Mike Havrilla • Comment!
Analysts Even More Bullish on ViroPharma

Dec 4, 2008 • Zacks.com • 3 Comments
Top Ten Magic Formula Stocks with Strong Relative Strength

Nov 17, 2008 • MagicDiligence • Comment!
Health Innovator's Index: Does R&D Lead to Higher Stock Prices?

Nov 13, 2008 • Mike Havrilla • Comment!
Biotech Update: Arena Pharmaceuticals, Acusphere, Cephalon, ViroPharma, Auxilium

Nov 3, 2008 • Zacks.com • 6 Comments
Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals

Oct 12, 2008 • Dan Weiss • 3 Comments
Viropharma, Lev Pharmaceuticals: An Attractive Biotech Pair

Oct 9, 2008 • Dan Weiss • 2 Comments
Biotech Names With Big Potential

Sep 23, 2008 • Zacks.com • 2 Comments
Watch for More Coming Biotech Acquisitions

Aug 3, 2008 • Zacks.com • 7 Comments
ViroPharma: Lev Acquisition Appraisal

Aug 3, 2008 • Value Geek • 10 Comments
Thursday Options Outlook: LEH, MER, XLF, SWY, VPHM, NUE, CIEN, MAR, CTSH

Jun 5, 2008 • Andrew Wilkinson • Comment!
American Campus Communities Issuing Secondary; Ulticom Mulling Sale

Apr 17, 2008 • John Phillips • Comment!
Is ViroPharma a Buy Despite Seemingly Weak Fundamentals?

Mar 13, 2008 • Donald Johnson • 2 Comments
Maribavir Should Guide Viropharma Higher

Mar 11, 2008 • Tony Kent • 3 Comments
ViroPharma Incorporated: More FDA Incompetence

Jan 18, 2008 • Theodore Cohen • 1 Comment
Forecast for ViroPharma's Pipeline: Mostly Shiny

Jan 14, 2008 • Brett Scott • 3 Comments

ViroPharma Inc. (VPHM)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers